Marijuana to Treat Attention Deficit Hyperactivity Disorder (ADHD)?
Many times, we judge the people around us because of behaviors that we believe are carried out on purpose. However, diseases such as depression cause a roller coaster of thoughts, emotions and attitudes not controlled by the sufferer. Often those ups and downs, can cause damage to yourself or people who love you. Many depression patients argue that cannabis helps manage levels of anxiety and negative thoughts.
And just as medicinal cannabis benefits those suffering from depression, there are other diseases that affect behavior, which can be treated with medicinal cannabis, and this time we want to refer to cannabis and ADHD.
In colloquial terms, people with ADHD have difficulty concentrating on tasks and cannot be quiet or calm. And in more scientific terms, it is established that attention deficit hyperactivity disorder is a neurological development disorder characterized by lack of attention, hyperactivity, and impulsivity. It affects around 6-9% of children and young adults and around 5% of all adults worldwide. Scientists believe that the condition may be due to the lack of dopamine in the region of the prefrontal cortex of the brain.
As a curious fact, it should be noted that dopamine is a neurotransmitter that affects thought processes, such as memory and attention.
A new treatment proposes cannabis to treat attention deficit hyperactivity disorder (ADHD). Some studies have shown that the connection between marijuana and positive therapeutic results in ADHD is limited. Some scientists are clear in determining that it is not satisfactory while on the other hand, other studies have suggested that marijuana would improve cognitive ability and impulse control.
We want to highlight a study conducted last year by Kings College in London, which aimed to test the effects of cannabinoids for the treatment of ADHD in adults. Half of them received a treatment with cannabinoids while the other half received a placebo. The results of this study showed that in the active group there was a significant difference in the levels of hyperactivity, as well as in the levels of lack of attention and emotional responsibility.
They found that cannabinoid treatment had no negative effects on levels of cognitive performance, which surprised many people because of the association between cannabis and a decrease in cognitive performance. On the other hand, the researchers suggested “improvements in impulsivity may be due to the anxiolytic effects of CBD and THC. The relaxing effects caused by cannabinoids may have been the reason for the decrease in the general behaviors associated with ADHD."
Analyzing the different positions and understanding that the medical, scientific, psychological and social debate that is generated concerning a disease is normal, there are two conclusions that we want to share: the first is to understand the medical conditions of other people and how the outright rejection of these studies has a negative impact. The second is that there is still a scientific vacuum on cannabis as a treatment for ADHD.
We invite doctors, scientists, chemists, businessmen, governors and patients to get involved in filling this gap. More research is needed, bills that support them and above all commitment.
Our invitation is also for you to participate in our upcoming seminars in Kansas City, Las Vegas and Austin. We hope to count on you, see you there and reaffirm this commitment.
